Waqar Usama, Hameed Ayesha Nasir, Angez Meher, Kumar Sudhesh, Arshad Hajra, Siddiqui Marium Tariq, Khan Hira, Viquar Werdah, Abbas Aiza, Javid Arsalan, Iftikhar Haissan, Abbas Syed Akbar, Naz Huma, Saleem Sarah
Medical College, Aga Khan University, Karachi, Pakistan.
Department of Surgery, University Hospitals Birmingham, United Kingdom.
Int Arch Otorhinolaryngol. 2024 Mar 15;28(3):e451-e459. doi: 10.1055/s-0043-1777804. eCollection 2024 Jul.
Despite the evidence against drain placement after thyroidectomy, there is a lack of consensus on drain use in patients with substernal goiter. To assess the factors that increase the likelihood of drain placement and its impact on postoperative hematoma and other 30-day complications among adult patients undergoing thyroidectomy for substernal goiter. A retrospective cohort study that used data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Adult patients (aged ≥ 18 years) who underwent elective thyroidectomy for substernal goiter from 2016 to 2020 were included. Cases with closed suction neck drains placed upon completion of surgery were included in the drain group, and the remaining cases formed the nondrain group. A total of 1,229 patients were included (46.5% with drain placement). The factors that increased the likelihood of drain placement included body mass index (BMI) ≥ 30 kg/m , score between 3 and 5 on the American Society of Anesthesiologists (ASA) physical status classification, sternal split/transthoracic surgical approach, operative time ≥ 90 minutes, and surgery conducted by otolaryngologists. Patients with clean-contaminated or contaminated wound classifications were less likely to be submitted to drain placement. In addition, drain use had no impact on postoperative hematoma formation but was found to independently increase the risk of prolonged length of hospital stay. Thyroidectomy without drain placement might be safe for substernal goiter. However, this decision should be individualized for each patient. Level Of Evidence: 3.
尽管有证据表明甲状腺切除术后无需放置引流管,但对于胸骨后甲状腺肿患者使用引流管尚无共识。为评估成年胸骨后甲状腺肿患者甲状腺切除术后放置引流管可能性增加的因素及其对术后血肿和其他30天并发症的影响。一项回顾性队列研究,使用了美国外科医师学会国家外科质量改进计划(ACS-NSQIP)的数据。纳入2016年至2020年因胸骨后甲状腺肿接受择期甲状腺切除术的成年患者(年龄≥18岁)。手术结束时放置闭式负压颈部引流管的病例纳入引流管组,其余病例组成无引流管组。共纳入1229例患者(46.5%放置了引流管)。增加放置引流管可能性的因素包括体重指数(BMI)≥30kg/m²、美国麻醉医师协会(ASA)身体状况分类评分在3至5分之间、胸骨劈开/经胸手术入路、手术时间≥90分钟以及由耳鼻喉科医生进行手术。伤口分类为清洁-污染或污染的患者放置引流管的可能性较小。此外,使用引流管对术后血肿形成没有影响,但发现会独立增加住院时间延长的风险。对于胸骨后甲状腺肿,不放置引流管的甲状腺切除术可能是安全的。然而,这一决定应针对每位患者个体化。证据级别:3。